Cipla announces major price reduction on select cancer drugs
Cipla Palliative Care Centre completes 15 years of caring for advanced stage cancer patients
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Sun Pharma to acquire DUSA Pharmaceuticals
DUSA’s Levulan combination therapy is for treatment of non-hyperkeratotic actinic keratoses
Quintiles study confirms validity of data from patients recruited over Internet
Lays foundation for direct-to-patient studies using patient reported outcomes + medical record methods
Novartis phase III study shows RLX030 improved symptoms and reduced deaths by one-third in patients…
RLX030 is the first in a new class of medicines and the only agent to show a reduction in mortality in AHF
IKP Knowledge Park announces Grand Challenges exploration
The goal of the IKP-GCE programme is to empower ideas that will create new drugs, diagnostics, devices, vaccines, delivery systems…
Pharmexcil expects Ministry notification on branding for drug exports within a week
Notification to clarify status and expected to bring relief to pharma exporters
Glenmark Generics announces settlement of Paragraph IV litigation with Janssen Pharmaceuticals
Glenmark will launch a generic version of ORTHO TRI-CYCLEN LO tablets as early as December 31, 2015
Cipla announces Q2 FY 12-13 unaudited financial results
Gross revenues grew by 23.6 per cent to Rs 2,220 crore